US 10610535
Diarylpropionitrile therapy for treatment of multiple sclerosis
granted A61KA61K31/565A61K31/57
Quick answer
US patent 10610535 (Diarylpropionitrile therapy for treatment of multiple sclerosis) held by The Regents of the University of California expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/565, A61K31/57